|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received on March 12, 2004
Accepted on June 28, 2004
Clinical Immunology |
1 Institute of Clinical Chemistry and Laboratory Medicine, Johannes Gutenberg University, Mainz, Germany
2 Department of Neurology, Johannes Gutenberg University, Mainz, Germany
* To whom correspondence should be addressed. E-mail: lackner{at}zentrallabor.klinik.uni-mainz.de.
Background: Intrathecal immunoglobulin synthesis is observed in several inflammatory disorders of the central nervous system, but its detection by current laboratory tests is either tedious or relatively insensitive. We assessed the diagnostic accuracy of an assay for
free light chains (
FLC) in cerebrospinal fluid (CSF) and serum, and compared it with traditional tests for intrathecal immunoglobulin synthesis.
Methods:
FLCs were measured by nephelometry in CSF/serum pairs from 112 patients. Samples were excluded if artificial blood contamination of CSF (n = 12) or monoclonal bands in both CSF and serum (n = 5) were present. The remaining sample pairs were grouped according to the presence (n = 71) or absence (n = 24) of oligoclonal bands. Data were analyzed as
FLC concentrations in CSF, as
FLC CSF/serum ratios, and by use of the quotient diagram described previously for immunoglobulins.
Results: Both
FLC concentrations in CSF and the
FLC CSF/serum ratio identified patients with oligoclonal bands with high specificity and sensitivity. The areas under the ROC curves were 0.991 (95% confidence interval, 0.944-0.998) and 0.978 (0.924-0.996), respectively. Exclusion of patients with impaired blood-CSF barrier function further improved diagnostic accuracy. To account for patients with impaired blood-CSF barrier function, data were also analyzed in a quotient diagram. Only two patients without detectable oligoclonal bands would have been misclassified by this approach.
Conclusions: Our data indicate that the nephelometric assay for
FLCs in CSF reliably detects intrathecal immunoglobulin synthesis. This automated and quantitative method could simplify the diagnostic procedure for CSF analysis in the routine laboratory.
The following articles in journals at HighWire Press have cited this article:
![]() |
M. Comabella, M. Fernandez, R. Martin, S. Rivera-Vallve, E. Borras, C. Chiva, E. Julia, A. Rovira, E. Canto, J. C. Alvarez-Cermeno, et al. Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis Brain, March 17, 2010; (2010) awq035v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Bradwell Serum Free Light Chain Measurements Move to Center Stage Clin. Chem., May 1, 2005; 51(5): 805 - 807. [Full Text] [PDF] |
||||
![]() |
E. J. Thompson Quality versus Quantity: Which Is Better for Cerebrospinal Fluid IgG? Clin. Chem., October 1, 2004; 50(10): 1721 - 1722. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |